Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
NEW Weight Loss Drug BETTER Than Mounjaro Is Keto Acv Gummies Safe For Diabetics
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-07-28
🩺 Ask Doctor Hansen:
An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen yet in a new class of drugs that’s revolutionizing the field.
The medicine, called retatrutide, had similar side effects – mainly gastrointestinal in nature – as approved drugs in the class, including Ozempic, Wegovy and Mounjaro, researchers reported in a study, funded by Lilly, published Monday in the New England Journal of Medicine. The results were also presented at the American Diabetes Association conference in San Diego.
#weightloss #diet #getlean #doctor #healthtips #healthylifestyle
NEW Weight Loss Drug BETTER Than Mounjaro For Country: United States. City: Alexandria, Atlanta, Chesapeake, El Paso, Winston-Salem
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication